Novartis Contract Manufacturing on LinkedIn: A Glimpse into the Future: Kundl's New Mammalian Drug Substance Facility (2024)

𝗘𝗹𝗲𝘃𝗮𝘁𝗶𝗻𝗴 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝘀 𝘄𝗶𝘁𝗵 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗯𝘆 𝗗𝗲𝘀𝗶𝗴𝗻 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 Wondering how we maintain top-notch manufacturing standards? This is done through our Quality by Design (QbD) approach, that enables us to optimize processes for speed and agility. By mastering the Critical Quality Attributes (CQAs) and process parameters, we prioritize safety and efficacy, while guaranteeing consistent high-quality products for our customers. Learn more about our manufacturing network following the framework by visiting our website: https://lnkd.in/eQkjRFgR.#QualityByDesign #Novartis #ContractManufacturing #CDMO

68

𝗔 𝗚𝗹𝗶𝗺𝗽𝘀𝗲 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲: 𝗞𝘂𝗻𝗱𝗹'𝘀 𝗡𝗲𝘄 𝗠𝗮𝗺𝗺𝗮𝗹𝗶𝗮𝗻 𝗗𝗿𝘂𝗴 𝗦𝘂𝗯𝘀𝘁𝗮𝗻𝗰𝗲 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝘆 Welcome to the future of pharmaceutical production at Novartis Kundl, Austria! Delve into the vision shared by Christian Eichmüller, Project Director & Senior Tech Transfer Lead, as he presents an update on our latest investment on Mammalian Drug Substance. The new facility symbolizes our dedication to innovation and sustainability, cutting energy consumption and carbon footprint by 50% compared to a conventional facility. With an annual capacity of 150 batches, producing 1.7 million liters of cell culture harvest, we are ready to meet the needs of our customers. #Novartis #Kundl #ContractManufacturing #CDMO #Mammalian

178

1 Comment

𝗪𝗼𝗿𝗹𝗱 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁 𝗗𝗮𝘆: 𝗢𝘂𝗿 𝗖𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁 𝘁𝗼 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 Happy World Environment Day! Today, we celebrate our planet and reaffirm our commitment to environmental sustainability. At Novartis Contract Manufacturing, we strive to minimize our impact on climate, waste, and water, aligning with our strategic priorities of operational excellence and building trust with society. Our new facilities feature automation, paperless batch records, digitalization, and green energy solutions. These efforts are part of our broader strategy to enhance efficiency and mitigate the impacts of climate change on human health and the planet. Learn more about our commitment to sustainability: https://lnkd.in/dickHRqE #WorldEnvironmentDay #Sustainability #Novartis #ContractManufacturing #CDMO

12

𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆: 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗮𝗻𝗱 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗶𝗻 𝗠𝗮𝗺𝗺𝗮𝗹𝗶𝗮𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 𝗧𝗿𝗮𝗻𝘀𝗳𝗲𝗿Exciting news! Join us in Munich for the Global Bioprocessing & Bio Technology Summit on June 7th. Sandip Bankar, PhD, Senior Scientist and Functional Lead at Novartis Austria, will be leading the talk on "Challenges and Opportunities in Large Scale Fermentation Process Transfer." Gain insights into cutting-edge bioprocessing techniques and discover innovative solutions to our industry challenges.#GlobalBioprocessingSummit #Novartis #ContractManufacturing #CDMO

225

9 Comments

𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗢𝘂𝘁𝘀𝗼𝘂𝗿𝗰𝗶𝗻𝗴 𝗦𝘂𝗺𝗺𝗶𝘁 𝗶𝗻 𝗕𝗲𝗿𝗹𝗶𝗻Join us at the European Pharma Outsourcing Summit on May 28th-29th, in Berlin! Don't miss our roundtable facilitated by Bettina Biechele, Manufacturing Unit Head at Novartis Operations. This session will provide insights from decades of CDMO business experience on how to drive long-term success through strategic partnerships. See you there!#EuropeanPharmaOutsourcingSummit #Novartis #ContractManufacturing #CDMO

119

2 Comments

𝗢𝘂𝘁𝘀𝗼𝘂𝗿𝗰𝗲𝗱 𝗣𝗵𝗮𝗿𝗺𝗮 𝗖𝗮𝗽𝗮𝗰𝗶𝘁𝘆 𝗨𝗽𝗱𝗮𝘁𝗲Join Carrie Bracco, our Head of Business Development, USA, for Outsourced Pharma Capacity Update on 20th May to learn more about our integrated offerings in mammaliandrug substance and drug product. Register at the link below to join the live session. #OutsourcedPharmaCapacityUpdate #Novartis #ContractManufacturing #CDMO

23

BIO International Convention: Join Us in San Diego! Get ready for the upcoming BIO International Convention in San Diego from June 3rd to 6th! Join us at Booth #4725 to explore our latest advancements in mammalian, viral vectors and discuss potential collaborations. Contact us to schedule a meeting through the link https://lnkd.in/eEDtKaAK or email us at novartis.cdmo@novartis.com Let's partner together to drive innovation in biologics, cell and gene therapy and oligonucleotides! #BIOUS #Novartis #ContractManufacturing #CDMO

43

Expanding Capacity in Novartis SingaporeExperience the growthof Novartis Singapore's production! Join Ana Locatelli, Site Head, Novartis Singapore, as she unveils the latest innovation technologies applied in the ongoing mammalian capacity expansion to supply sustainable and high quality medicines to patients globally. Witness innovation in action as we pave the way for a sustainable future in pharmaceutical manufacturing!#Novartis #Singapore #ContractManufacturing #CDMO #Mammalian

761

8 Comments

ASGCT Meeting in Baltimore We are thrilled to announce that we will be joining the ASGCT Annual Meeting in Baltimore from May 7th to 11th! Join us for five days of cutting-edge advancements in gene and cell therapy. Don't miss this opportunity to connect and book an appointment with us through novartis.cdmo@novartis.com with your preferred date & time. #ASGCT2024 #GeneandCellTherapy #Novartis #contractmanufacturing #CDMO

31